Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognostic factors in a randomized multicenter clinical trial “DLBCL-2015”

Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognostic factors in a randomized multicenter clinical trial “DLBCL-2015”

Background. Diffuse large B-cell lymphoma (DLBCL) is one of the most common and aggressive tumors of the lymphatic system. Despite the frequency of occurrence, there is no single algorithm for treating DLBCL patients with poor prognostic factors. R-CHOP therapy does not allow achieving long-term com...

Full description

Saved in:
Bibliographic Details
Main Authors: M. O. Bagova, A. U. Magomedova, S. K. Kravchenko, Ya. K. Mangasarova, O. V. Margolin, E. S. Nesterova, L. G. Gorenkova, A. E. Misyurina, E. A. Fastova, F. E. Babaeva, K. A. Sychevskaya, S. M. Kulikov, Yu. A. Chabaeva, V. G. Savchenko
Format: Article
Language:Russian
Published: ABV-press 2021-09-01
Series:Онкогематология
Subjects:
diffuse large b-cell lymphoma
toxicity
effectiveness
r-da-epoch
r-mnhl-bfm-90
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/491
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://oncohematology.abvpress.ru/ongm/article/view/491

Similar Items